Ligand · VO2
VO2 · 3-(benzyloxy)-5-methyl-N-(4-methyl-1,3-thiazol-2-yl)pyridin-2-amine
VO2, 3-(benzyloxy)-5-methyl-N-(4-methyl-1,3-thiazol-2-yl)pyridin-2-amine (C17 H17 N3 O S, 311.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- VO2
- Formula
- C17 H17 N3 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VO2 in 2 structures; the first of them:
- 4MLH · Human Glucokinase in Complex with a Novel Amino Thiazole Allosteric Activator · VO2 A502 · binds TYR61, VAL62, ARG63, SER64, PRO66, GLN98, ILE159, MET210 and 8 more
- 4MLH · Human glucokinase in complex with a novel amino thiazole allosteric activator · VO2 A502 · binds TYR61, VAL62, ARG63, SER64, PRO66, GLN98, ILE159, MET210 and 8 more
Residues it binds most
VAL 2, ILE 2, MET 2, TYR 2, ARG 2, CYS 2, GLN 2, GLU 2, LEU 2, PRO 2 (residue and the binding sites it lines).
Found with
- GLC · alpha-D-glucopyranose
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.